Shunji Takahashi

17PUBLICATIONS
98CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyDependable systemsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 14, 2026
Extracellular Vesicle IL5RA and BCMA in Serum Enable Non-Invasive Risk Stratification of Multiple Myeloma.

Yuko Shirouchi, Hiroki Shinchi, Yoshimi Haga

|Mar 12, 2026
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.

Lisa Licitra, Makoto Tahara, Kevin Harrington

|Dec 15, 2025
The first case of <i>GOLGA5-RET</i> fusion-positive malignant spindle cell sarcoma of the head and neck responsive to selpercatinib.

Takehiro Nakao, Naoki Fukuda, Xiaofei Wang

|May 05, 2025
Automated and Decentralized Genomic Profiling of Plasma Cell-Free DNA for Identification of Targetable and Resistance Alterations in Advanced Solid Tumors.

Hiu Ting Chan, Masumi Otaki, Naomi Hayashi

|Mar 31, 2025
Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective study.

Takane Watanabe, Hiroki Oka, Kengo Nagashima

|Mar 05, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma.

Sumanta K Pal, Alice Bernard-Tessier, Peter Grell

Pageof 3

Frequent Collaborators

3 joint publications

Junichi Tomomatsu

3 joint publications

Kenji Nakano

2 joint publications

Yasuyoshi Sato

2 joint publications

Naoki Fukuda